Pharmacokinetic Study of ORM-12741 After Multiple Oral Doses
Phase of Trial: Phase I
Latest Information Update: 05 May 2015
At a glance
- Drugs ORM 12741 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Acronyms Nebula PK 2
- Sponsors Orion
- 05 May 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Jan 2015 as per ClinicalTrials.gov record.
- 05 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 04 Dec 2014 New trial record